Sakon Earns EcoVadis Committed Badge for Sustainability Performance 
Bring Your Toughest AM Quality Problem To Formnext: Amsight Challenges Manufacturers To Rethink Production Quality Siemens Investing $54M in Its U.S. Manufacturing Footprint to Support National Infrastructure Projects
Siemens to invest in existing and new sites in Texas and California that develop electrical…
Cowboy Midstream, LLC Plans New Crude Offload Terminal
CASPER, Wyo.–(BUSINESS WIRE)–Cowboy Midstream (Cowboy), a full-service midstream provider, has announced the planned opening of…
VALNEVA Declaration of shares and voting rights – February 28, 2022
VALNEVA Declaration of shares and voting rights February 28, 2022__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6…
DunhamTrimmer Publishes Authoritative Market Report on Biofertilizers
Bio-industry intelligence firm releases insider analysis of rapidly growing global Biofertilizer market LAKEWOOD RANCH, Fla.–(BUSINESS…
Analog Devices Invests €100 Million in Europe Operations with ADI Catalyst Launch
Designed to Accelerate Collaborative Innovation and Support R&D in Europe WILMINGTON, Mass. & LIMERICK, Ireland–(BUSINESS…
Holly Energy Partners, L.P. Files 2021 Form 10-K
DALLAS–(BUSINESS WIRE)–On February 23, 2022, Holly Energy Partners, L.P. (NYSE: HEP) (the “Partnership”) filed with…
Midwest Bank Partners With Lendsmart to Streamline the Entire Homebuying Journey
NEW YORK–(BUSINESS WIRE)–#banking—Midwest Bank, a locally-owned community bank, providing loans, mortgages, financial planning and investment…
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2021 Financial Results
Encouraging preliminary results from BALLI-01 study (evaluating UCART22) in relapsed/refractory B-cell Acute Lymphoblastic Leukemia presented…
Travere Therapeutics to Present at the Barclays Global Healthcare Conference
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT…
BioSyent Schedules Q4 and Full Year 2021 Earnings Release for March 9, 2022
MISSISSAUGA, Ontario, March 03, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
Viridian Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Host Investor Conference Call on March 10, 2022
WALTHAM, Mass., March 03, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology…
Histogen to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Business Update
SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics…
DBV Technologies Reports Full Year 2021 Financial Results and Recent Business Updates
Montrouge, France, March 3, 2022 DBV Technologies Reports Full Year 2021 Financial Results and Recent…
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2021
– Approximately $113 Million of U.S. Product Sales in 2021 – – Approximately $13 Million…
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
-Top-line data readout from TERN-201 (VAP-1 inhibitor) clinical trial in NASH expected in March 2022…
Satsuma Pharmaceuticals Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2022 Annual Meeting
SOUTH SAN FRANCISCO, Calif., March 03, 2022 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
IO Biotech Announces Appointment of David V. Smith to its Board of Directors
NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Rain Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Progress
– Quarter-end cash position of $140.2 million provides runway to complete all ongoing and planned…
NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Multiple data readouts expected in 2022, including updates for all three clinical programs Ends 2021…